SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma

MLA

Lunxu Liu, et al. SKA1/2/3 Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma. Apr. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....20299f065af6f43a52a72866fa676652&authtype=sso&custid=ns315887.

APA

Lunxu Liu, Yongxiang Song, Gang Xu, Cheng Chen, & Qiang Guo. (2020). SKA1/2/3 serves as a biomarker for poor prognosis in human lung adenocarcinoma.

Chicago

Lunxu Liu, Yongxiang Song, Gang Xu, Cheng Chen, and Qiang Guo. 2020. “SKA1/2/3 Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma,” April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....20299f065af6f43a52a72866fa676652&authtype=sso&custid=ns315887.